Follow The Filings

XENE position history

The shares of Xenon Pharmaceuticals (XENE) that BAMCO Inc (Baron Capital) reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2021 Q4: 42,000 shares, $1.3M, <0.01% of portfolio, New
  2. 2022 Q1: 42,000 shares, $1.3M, <0.01% of portfolio
  3. 2022 Q2: 22,000 shares, $669K, <0.01% of portfolio, Reduce −47.6%
  4. 2022 Q3: 27,500 shares, $993K, <0.01% of portfolio, Add +25.0%
  5. 2022 Q4: 47,400 shares, $1.9M, <0.01% of portfolio, Add +72.4%
  6. 2023 Q1: 73,000 shares, $2.6M, <0.01% of portfolio, Add +54.0%
  7. 2023 Q2: 100,100 shares, $3.9M, 0.01% of portfolio, Add +37.1%
  8. 2023 Q3: 100,100 shares, $3.4M, <0.01% of portfolio
  9. 2023 Q4: 100,100 shares, $4.6M, 0.01% of portfolio
  10. 2024 Q1: 100,100 shares, $4.3M, 0.01% of portfolio
  11. 2024 Q2: 100,100 shares, $3.9M, 0.01% of portfolio
  12. 2024 Q3: 100,100 shares, $3.9M, 0.01% of portfolio
  13. 2024 Q4: 100,100 shares, $3.9M, 0.01% of portfolio
  14. 2025 Q1: 100,100 shares, $3.4M, <0.01% of portfolio
  15. 2025 Q2: 56,000 shares, $1.8M, <0.01% of portfolio, Reduce −44.1%
  16. 2025 Q3: 30,000 shares, $1.2M, <0.01% of portfolio, Reduce −46.4%
  17. 2025 Q4: 30,000 shares, $1.3M, <0.01% of portfolio
  18. 2026 Q1: 25,000 shares, $1.5M, <0.01% of portfolio, Reduce −16.7%
  19. 2026 Q2: 25,000 shares, $1.5M, <0.01% of portfolio
Holdings date Value % of holdings Shares Filing date All 13F holders